Healthcare provider profile · identity verified

Radwan A Ibrahim, M.D.

Internal Medicine · GASTONIA, NC · NPI 1497740682

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	709	41
Gabapentin	Gabapentin	638	38
Metformin Hcl	Metformin Hcl	520	30
Olanzapine	Olanzapine	501	20
Trazodone Hcl	Trazodone Hcl	431	30
Amlodipine Besylate	Amlodipine Besylate	388	28
Risperidone	Risperidone	347	14
Quetiapine Fumarate	Quetiapine Fumarate	319	11
Omeprazole	Omeprazole	313	27
Lisinopril	Lisinopril	310	30
Levothyroxine Sodium	Levothyroxine Sodium	249	16
Sertraline Hcl	Sertraline Hcl	247	13
Furosemide	Furosemide	230	21
Divalproex Sodium	Divalproex Sodium	222	11
Pantoprazole Sodium	Pantoprazole Sodium	198	19
Divalproex Sodium Er	Divalproex Sodium	191	suppressed
Clozapine	Clozapine	184	suppressed
Alprazolam	Alprazolam	172	suppressed
Benztropine Mesylate	Benztropine Mesylate	167	suppressed
Metoprolol Succinate	Metoprolol Succinate	159	suppressed
Potassium Chloride	Potassium Chloride	152	11
Lorazepam	Lorazepam	148	16
Tramadol Hcl	Tramadol Hcl	148	17
Tamsulosin Hcl	Tamsulosin Hcl	145	17
Aripiprazole	Aripiprazole	139	suppressed
Famotidine	Famotidine	139	suppressed
Metformin Hcl Er	Metformin Hcl	126	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	124	suppressed
Losartan Potassium	Losartan Potassium	122	suppressed
Pravastatin Sodium	Pravastatin Sodium	121	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	119	11
Bupropion Xl	Bupropion Hcl	118	suppressed
Duloxetine Hcl	Duloxetine Hcl	104	suppressed
Montelukast Sodium	Montelukast Sodium	102	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	88	suppressed
Clonazepam	Clonazepam	82	suppressed
Paroxetine Hcl	Paroxetine Hcl	82	suppressed
Warfarin Sodium	Warfarin Sodium	78	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	suppressed
Jardiance	Empagliflozin	74	suppressed
Meloxicam	Meloxicam	74	suppressed
Lithium Carbonate	Lithium Carbonate	73	suppressed
Eliquis	Apixaban	72	suppressed
Fluticasone Propionate	Fluticasone Propionate	72	14
Levetiracetam	Levetiracetam	72	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	suppressed
Mirtazapine	Mirtazapine	71	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	70	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	70	suppressed
Clopidogrel	Clopidogrel Bisulfate	67	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	66	suppressed
Valsartan	Valsartan	66	suppressed
Allopurinol	Allopurinol	64	suppressed
Paliperidone Er	Paliperidone	64	suppressed
Fluconazole	Fluconazole	59	suppressed
Invega Sustenna	Paliperidone Palmitate	58	suppressed
Oxcarbazepine	Oxcarbazepine	58	suppressed
Propranolol Hcl Er	Propranolol Hcl	58	suppressed
Baclofen	Baclofen	55	suppressed
Ibuprofen	Ibuprofen	54	11
Buspirone Hcl	Buspirone Hcl	53	suppressed
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Donepezil Hcl	Donepezil Hcl	50	suppressed
Memantine Hcl	Memantine Hcl	49	suppressed
Ozempic	Semaglutide	49	suppressed
Celecoxib	Celecoxib	48	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	46	12
Colestipol Hcl	Colestipol Hcl	46	suppressed
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Prazosin Hcl	Prazosin Hcl	46	suppressed
Colesevelam Hcl	Colesevelam Hcl	45	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	44	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	43	suppressed
Niacin Er	Niacin	43	suppressed
Ursodiol	Ursodiol	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	42	suppressed
Haloperidol	Haloperidol	41	suppressed
Finasteride	Finasteride	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Promethazine Hcl	Promethazine Hcl	37	suppressed
Perphenazine	Perphenazine	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	11
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Linzess	Linaclotide	32	suppressed
Prednisone	Prednisone	32	14
Azithromycin	Azithromycin	30	25
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Pregabalin	Pregabalin	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Trintellix	Vortioxetine Hydrobromide	27	suppressed
Amantadine	Amantadine Hcl	26	suppressed
Primidone	Primidone	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Topiramate	Topiramate	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Atropine Sulfate	Atropine Sulfate	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Digoxin	Digoxin	20	suppressed
Lacosamide	Lacosamide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Dofetilide	Dofetilide	15	suppressed
Drospirenone-Ethinyl Estradiol	Ethinyl Estradiol/Drospirenone	15	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	15	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Ulticare Safety Pen Needle	Pen Needle, Diabetic, Safety	14	suppressed
Abilify Maintena	Aripiprazole	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Mercaptopurine	Mercaptopurine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Atenolol	Atenolol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Invokana	Canagliflozin	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error